Fundz

Galectin Therapeutics Appoints Khurram Jamil, M.D. as Vice President, Clinical Development

PUBLIC · GALTMar 12, 2024

Position

Vice President of Clinical Development

Company

Galectin

Khurram Jamil, M.D.
jamil@galectintherapeutics.com
NorcrossBiotechnologyHealthcareHealth CareTherapeutics

Description

Galectin Therapeutics appoints Khurram Jamil, M.D. as Vice President, Clinical Development

Quick answer

Galectin Therapeutics Appoints Khurram Jamil, M.D. as Vice President, Clinical Development (March 12, 2024). Galectin is based in Norcross, Georgia, United States.

Who is the new Vice President of Clinical Development at Galectin?
Galectin named Khurram Jamil, M.D. Vice President of Clinical Development, announced March 12, 2024.
What did Galectin announce on March 12, 2024?
Galectin Therapeutics appoints Khurram Jamil, M.D. as Vice President, Clinical Development
What does Galectin do?
The NAVIGATE trial (NAVIGATEnash.com), entitled “A Seamless Adaptive Phase 2b/3, Double-Blind, Randomized, Placebo-controlled Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR-MD-02)...
Where is Galectin based?
Galectin is based in Norcross, Georgia, United States.
Which similar companies made leadership changes around the same time?
Madrigal Pharmaceuticals (March 11, 2024), Ocugen (March 18, 2024), Elevation Oncology (March 4, 2024) and EyePoint, Inc. (March 4, 2024) also announced leadership changes within 45 days of Galectin.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Galectin, and when

A new leader at Galectin brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Galectin raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Galectin, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Galectin. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Galectin

Location

Norcross, Georgia, United States

About

The NAVIGATE trial (NAVIGATEnash.com), entitled “A Seamless Adaptive Phase 2b/3, Double-Blind, Randomized, Placebo-controlled Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR-MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis” began randomization of patients in August, 2020, and is posted on www.clinicaltrials.gov (NCT04365868). Galectin-3 has a significant role in cancer, and the Company has supported a Phase 1b study in combined immunotherapy of belapectin and KEYTRUDA in advanced melanoma and in head and neck cancer. This trial provided a strong rationale for moving forward into a Phase 2 development program which the company is considering.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Galectin changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Sharisse
Senior decision-maker at this company
••••••••@••••••••

See Sharisse's verified email →

Jack
Likely contact at this company
••••••••@••••••••

See Jack's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Galectin's next move

Learn about Strategic plan

Galectin changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.